Clinical Resources

Potential stem cell-derived therapies are advancing from the laboratory towards the clinic. These cell-based approaches present novel considerations for clinicians and the public alike. The ISSCR is dedicated to helping educate and inform clinicians, review boards, and the public with current, scientifically-grounded information on these advances and their application(s).




Guidelines that outline core principles of scientific rigor and research integrity, regularly updated based on scientific developments and disseminated to researchers, clinicians, organizations and institutions around the world.


The ISSCR Comments on the MHRA Consultation on Point of Care Manufacturing

  • 23 September, 2021
News from ISSCR website tile The ISSCR submitted comments to the UK's MHRA on the Consultation on Point of Care Manufacturing that state, among other key points:  We are particularly concerned that purveyors of autologous adipose-derived cell therapies might seek to exploit the regulations to sell adipose-derived cells for indications that they have not been shown to treat effectively. These therapies and all ATMPs should be preceded by well-regulated trials and testing that demonstrate the safety, efficacy, and quality of such products.

Read the comments.